Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT00576654 · COMPLETED

Trial details

NCT number: NCT00576654
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm Triple-Negative Breast Carcinoma Unresectable Solid Neoplasm

Start date: 2008-03-18
Primary completion: 2020-01-16
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.